Daniel R. Chevallard

Chief Financial Officer

Chief Financial Officer at LENZ Therapeutics, Inc., filing insider transactions on 2026-03-27.

Total Purchases

$64K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-03-27

Last: 2026-03-27

Companies

LENZ Therapeutics, Inc.

Other Reporting Insiders at LENZ Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-03-27	LENZ	Purchase	7,500	$8.57	$64K	12.9K	SEC ↗

Daniel R. Chevallard (LENZ Therapeutics, Inc.) Insider Trades | Tormere